Avidity Biosciences, Inc. (RNA) Asset Utilization Ratio (2020 - 2025)
Avidity Biosciences' Asset Utilization Ratio history spans 6 years, with the latest figure at 0.01 for Q4 2025.
- For Q4 2025, Asset Utilization Ratio rose 34.78% year-over-year to 0.01; the TTM value through Dec 2025 reached 0.01, up 34.78%, while the annual FY2025 figure was 0.01, 7.14% up from the prior year.
- Asset Utilization Ratio reached 0.01 in Q4 2025 per RNA's latest filing, down from 0.01 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.03 in Q2 2021 to a low of 0.01 in Q1 2025.
- Average Asset Utilization Ratio over 5 years is 0.02, with a median of 0.02 recorded in 2023.
- Peak YoY movement for Asset Utilization Ratio: crashed 60.45% in 2024, then soared 75.95% in 2025.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.02 in 2021, then fell by 21.06% to 0.02 in 2022, then fell by 7.77% to 0.02 in 2023, then crashed by 57.26% to 0.01 in 2024, then skyrocketed by 34.78% to 0.01 in 2025.
- Per Business Quant, the three most recent readings for RNA's Asset Utilization Ratio are 0.01 (Q4 2025), 0.01 (Q3 2025), and 0.01 (Q2 2025).